Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis.

Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis. Abstract Text:

Dana K Andersen,

OBJECTIVES: Exocrine and endocrine abnormalities in chronic pancreatitis contribute to the morbidity and mortality risks of the disease. Complications of exocrine insufficiency include malabsorption, vitamin deficiency syndromes, and weight loss. Oral enzyme replacement therapy is usually effective if attention is paid to factors that affect the bioavailability of enzyme preparations. Complications of endocrine insufficiency can be more difficult to treat due in part to an incomplete knowledge of their etiology. METHODS: This review focuses on the endocrine aspects of chronic pancreatitis and highlights the observations of our laboratory on the pathogenesis of the metabolic complications of the disease. RESULTS: In addition to decreased insulin secretory capacity, pancreatogenic (or apancreatic) diabetes is characterized by decreased or absent glucagon and pancreatic polypeptide (PP) secretion, a loss of hepatic insulin receptor (IR) expression/availability, and an impairment in hepatic IR function (phosphorylation and endocytosis). Diminished hepatic IR expression in chronic pancreatitis appears to be because of PP deficiency; laboratory animals and patients with PP deficiency demonstrate decreased hepatic IR availability that is reversed by prolonged (8-hour) PP administration. The impairment in hepatic IR function appears independent of PP deficiency but is reversed by prolonged (28-day) treatment with the insulinotropic/insulinomimetic hormone glucagon-like peptide 1. The endocytosis of hepatic IR is linked to the endocytosis of the glucose transporter 2 from the hepatocyte plasma membrane, and studies suggest that the 2 plasma membrane-bound proteins are complexed noncovalently to function and translocate as a unit after insulin binding to the hepatic IR. The process appears vigorous and sensitive enough to account for a significant reduction in hepatic glucose output and may represent a major mechanism for insulin regulation of hepatic glucose production. CONCLUSIONS: The regulatory mechanisms of PP-mediated hepatic IR expression and combined IR and GLUT2 endocytosis after insulin binding are defective in chronic pancreatitis and contribute to the apancreatic diabetes, which characterizes this disease.

Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis. Publishing Authors By Initials

DK Andersen,

For similar digestive system diseases: pancreatic diseases: pancreatitis: pancreatitis, chronic research abstracts see: digestive system diseases: pancreatic diseases: pancreatitis: pancreatitis, chronic research

PUBMED ID PMID:

MEDLINE DATE:

Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis. Journal Published:

PUBLICATION TYPE: Review

Journal: Pancreas

VOLUME: 35

Page Numbers: 1-15

Journal Abbreviation: Pancreas

ISSN: 1536-4828

DAY: 3

MONTH: Jul

YEAR: 2007

Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis. Information

Number of References: 82

LANGUAGE: eng

NlmUniqueID: 8608542

Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis. Keywords Mesh Terms:

KEYWORDS: Pancreatitis, Chronic

MESH TERMS: therapy

Chemical & Substance for Abstract: Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis.

AFFILIATION: Department of Surgery, Johns Hopkins University Medical School, and Johns Hopkins Bayview Medical Center, Baltimore, MD 21224, USA. dander54@jhmi.edu

Country: United States

AGENCY: United States NIDDK

GRANT: DK39950

ACRONYM: DK

MEDLINETA: Pancreas

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis Related Publications

• 2,3-butanedione monoxime affects cystic fibrosis transmembrane conductance regulator channel function through phosphorylation-dependent and phosphorylation-independent mechanisms: the role of bilayer material properties.
• 494.
• A floating metal microelectrode array for chronic implantation.
• A new multi-site probe array with monolithically integrated parylene flexible cable for neural prostheses.
• Aluminium in peritoneal dialysis fluids as determined by stabilised temperature platform furnace atomic absorption spectrometry.
• Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins.
• Body change stress for women with breast cancer: the Breast-Impact of Treatment Scale.
• Brain activity during stimulation of the trigeminal nerve with noxious heat.
• Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration.
• Deceptive simplicity: systemic oxygen delivery and pulse oximetry.
• Docosahexaenoic acid alters bilayer elastic properties.
• Graded semantic and phonological similarity effects in priming: evidence for a distributed connectionist approach to morphology.
• Hepatic sequestration of chlordecone and hexafluoroacetone evaluated by pharmacokinetic modeling.
• In vitro and in vivo neuroprotection by gamma-glutamylcysteine ethyl ester against MPTP: relevance to the role of glutathione in Parkinson's disease.
• Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age.
• Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration.
• Long-term follow-up comparison of durasphere and contigen in the treatment of stress urinary incontinence.
• Low cardiorespiratory fitness is a strong predictor for clustering of cardiovascular disease risk factors in children independent of country, age and sex.
• Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis.
• Meeting report: Sloan Foundation Workshop to resolve problems relating to the taxonomy of microorganisms and to culture collections arising from the barcoding initiatives; Portland ME, November 6-7, 2006.
• Moderators' summary: wound management (session I).
• Muscle fibre number varies with haemoglobin phenotype in Atlantic cod as predicted by the optimal fibre number hypothesis.
• Nine-year prediction of adolescent smoking by number of smoking parents.
• Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease.
• Social Inequalities in Level of Physical Activity and Overweight among 9-year old Children: 2603: Board #150 June 2 8:00 AM - 9:30 AM.
• Strategies used in coping with a cancer diagnosis predict meaning in life for survivors.
• Studies of the organization of the human nociceptive withdrawal reflex*.
• Survey of pesticide residues in table grapes: determination of processing factors, intake and risk assessment.
• The Grainyhead-like epithelial transactivator Get-1/Grhl3 regulates epidermal terminal differentiation and interacts functionally with LMO4.
• The ground dominance effect in the perception of relative distance in 3-D scenes is mainly due to characteristics of the ground surface.